Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v5-FR Version v2-FR
Language French French
Date Updated 2023-08-04 2022-11-14
Drug Identification Number 02425890 02425890
Brand name IBAVYR IBAVYR
Common or Proper name IBAVYR IBAVYR
Company Name PENDOPHARM DIVISION OF PHARMASCIENCE INC PENDOPHARM DIVISION OF PHARMASCIENCE INC
Ingredients RIBAVIRIN RIBAVIRIN
Strength(s) 400MG 400MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100 100
ATC code J05AP J05AP
ATC description
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-11-14 2022-11-14
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments See discontinuation report 182029
Health Canada comments